Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -28.90% vs -16.59% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -8,366.67% vs 100.29% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -430.65% vs 106.35% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -66.67% vs 200.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Staidson (Beijing) Biopharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -0.32% vs -2.68% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.90% vs -16.59% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -463.64% vs 96.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8,366.67% vs 100.29% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -1,676.92% vs 104.74% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -430.65% vs 106.35% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -80.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -66.67% vs 200.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






